SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is trending following a significant earnings beat and a double-digit revenue jump that defied recent bearish sentiment, fueling active community debates over the sustainability of its AI-driven turnaround. Investors are closely monitoring the company's aggressive capital expenditure plans and the lack of named foundry customers, which have sparked both bullish excitement about long-term potential and skepticism from those concerned about potential future dilution.

Zevra Therapeutics, Inc. is a commercial-stage rare disease company that combines science, data and patient needs to create therapies for diseases with limited or no treatment options. The firm focuses on the treatment of rare neurological and sleep conditions such as certain Urea Cycle Disorders, Niemann Pick Disease Type C and Idiopathic Hypersomnia. The company receives royalties for AZSTARYS from its commercial partner Corium. The company was founded by Christal M. M. Mickle and Travis C. Mickle on October 30, 2006 and is headquartered in Celebration, FL.

Zevra Therapeutics Inc

Zevra Therapeutics is trending as the community closely monitors a potential European regulatory milestone for its flagship drug, MIPLYFFA, following the recent addition of a patent extension to 2041. Investors are actively debating the timing and likelihood of a positive EMA opinion while reacting to a flurry of recent analyst price target upgrades and high institutional interest.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers Health Inc. is trending as investors react to an FDA advisory panel's positive vote on the compounding of several peptides, viewed as a catalyst for potential market expansion. While some in the community highlight the stock's significant short interest and long-term potential, others are actively debating whether the regulatory news is a "buy the rumor, sell the news" event or a fundamental shift in the company's healthcare platform.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is trending as the community anticipates CEO Dr. Angelos Stergiou's upcoming media appearance, which is expected to highlight AI's role in advancing cancer immunotherapy and oncology. Investors are closely monitoring the potential for trial-related updates as the REGAL Phase 3 study nears its final event count, fueling discussions about long-term potential and institutional interest.

Deckers Outdoor Corp. engages in the business of designing, marketing, and distributing footwear, apparel, and accessories developed for both everyday casual lifestyle use and high performance activities. It operates through the following segments: UGG Brand, HOKA Brand, Teva Brand, Sanuk Brand, Other Brands, and Direct-to-Consumer. The UGG Brand segment offers a line of premium footwear, apparel, and accessories. The HOKA Brand segment sells footwear and apparel that offers enhanced cushioning and inherent stability with minimal weight, originally designed for ultra-runners. The Teva Brand segment focuses on the sport sandal and modern outdoor lifestyle category, such as sandals, shoes, and boots. The Sanuk Brand segment originated in Southern California surf culture and has emerged into a lifestyle brand with a presence in the relaxed casual shoe and sandal categories. The Other Brands segment includes the Koolaburra by UGG brand. The Direct-to-Consumer segment consists of retail stores and e-commerce websites. The company was founded by Douglas B. Otto in 1973 and is headquartered in Goleta, CA.

Deckers Outdoor Corp.

Deckers Outdoor is trending as investors react to a strong quarterly beat and raised guidance, fueling community debate over whether the stock is finally breaking out of its range or if the rally is a temporary "buy the rumor, sell the news" event. Traders are actively discussing the impact of the company's aggressive share buyback program and whether HOKA's continued growth can offset concerns regarding broader retail sector pressures and shifting analyst sentiment.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is currently experiencing extreme volatility as investors react to management's aggressive AI and robotics spending plans, leading to intense debate among community members over whether this represents a long-term buying opportunity or the end of the stock's growth narrative. The discourse is heavily fueled by technical traders monitoring critical support levels for a potential bounce, while bears and bulls clash over the viability of Musk's long-term vision versus the company's immediate financial performance.

Globalstar, Inc. engages in the provision of mobile satellite services. It offers voice and data communications services to the following markets: recreation and personal, government, public safety and disaster relief, oil and gas, maritime and fishing, natural resources, mining, and forestry, construction, utilities, and transportation. The company was founded in November 2003 and is headquartered in Covington, LA.

Globalstar Inc.

Globalstar is trending as investors monitor the pending acquisition by Amazon, with many in the community debating if a higher counter-offer from competitors could still emerge despite the deal. Sentiment remains focused on the valuation of the company's spectrum assets and the potential implications of recent regulatory rulings on future bidding activity.

Albertsons Cos., Inc. engages in the operation of food and drug retail stores. It offers grocery products, general merchandise, health and beauty care products, pharmacy, fuel, and other items and services. The company was founded by Joe Albertson on July 21, 1939 and is headquartered in Boise, ID.

Albertsons Companies Inc - Ordinary Shares - Class A

Albertsons is experiencing significant volatility driven by a major earnings miss and a sharp reduction in full-year guidance, which has left investors debating whether the stock is a distressed value play or facing long-term structural decline. The community is actively discussing signs of capitulation, the impact of competitive pressure from discount grocers, and speculative hope that the company could become an attractive acquisition target despite its current challenges.

Hewlett Packard Enterprise Co. is a global edge-to-cloud company, which engages in the provision of information technology, technology and enterprise products, solutions, and services. It operates through the following segments: Server, Hybrid Cloud, Intelligent Edge, Financial Services, and Corporate Investments and Other. The Server segment consists of general-purpose servers for multi-workload computing and workload-optimized servers to deliver the performance and value for demanding applications, and integrated systems comprised of software and hardware designed to address high-performance computing and supercomputing, artificial intelligence, data analytics, and transaction processing workloads for government and commercial customers globally. The Hybrid Cloud segment is involved in a variety of cloud-native and hybrid solutions across storage, private cloud, and the infrastructure software-as-a-service space. The Intelligent Edge segment offers wired and wireless local area networks, campus, branch, and data center switching, software-defined wide-area-networks, private and public cellular network software, network security, and associated services that enable secure connectivity for businesses of any size. The Financial Services segment provides investment solutions, such as leasing, financing, IT consumption, utility programs, and asset management services for customers that facilitate technology deployment models and the acquisition of complete IT solutions, including hardware, software, and services from Hewlett Packard Enterprise and others. The Corporate Investments and Other segment includes the Advisory and Professional Services business, which primarily offers consultative-led services, HPE and partner technology expertise and advice, implementation services, as well as complex solution engagement capabilities, the Communications and Media Solutions business, which primarily offers software and related services to the telecommunications industry, and Hewlett Packard Labs, which is responsible for research and development. The company was founded by William R. Hewlett and David Packard on July 2, 1939 and is headquartered in Spring, TX.

Hewlett Packard Enterprise Co

Hewlett Packard Enterprise is trending as investors weigh its strong AI infrastructure backlog and server demand against sector-wide volatility and technical price resistance near $50. While community members discuss its long-term potential as an AI play, there is active debate over whether the stock is undervalued given its earnings momentum or if it is currently suffering from profit-taking and institutional rotation.

Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which engages in the development of novel therapies for the management of central nervous system disorders. Its portfolio consists of Products Overview and Pipeline Overview. The Products Overview includes Auvelity and Sunosi. The Pipeline Overview refers to AXS-05, AXS-07, AXS-12, and AXS-14. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.

Axsome Therapeutics Inc

Axsome Therapeutics is trending following the FDA approval of Auvelity for the treatment of agitation associated with Alzheimer’s disease, a milestone that community members view as a significant de-risking event and a major growth catalyst. Investors are actively discussing the expanded peak sales potential and the clean label status of the drug, which many believe positions the company as a prime target for future acquisition or long-term value creation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$HIMS Pay attention to the language folks. Whether it’s an interview on tv or a letter sent to the companies - they keep using the same language over and over and over. Key words: claims, advertisements, marketing. 

This is a marketing issue.

Love

Jamal Anderson

JuliusW

Hdawg

$LLY $NVO $HIMS  
 
FDA warns 30 telehealth companies against illegal marketing of compounded GLP-1s 
 
The U.S. Food and Drug Administration announced the issuance of 30 warning letters to telehealth companies for making false or misleading claims regarding compounded GLP-1 products offered on their websites. &quot;It&#39;s a new era. We are paying close attention to misleading claims being made by telehealth and pharma companies across all media platforms-and taking swift action,&quot; said FDA Commissioner Marty Makary, M.D., M.P.H. &quot;Compounded drugs can be important for overcoming shortages or meeting unique patient needs-but compounders should not try to compound drugs in a way that circumvents FDA&#39;s approval process.&quot; This is the second group of warning letters sent to telehealth firms since the agency launched in September a crackdown on misleading direct-to-consumer pharmaceutical advertisements.  
 
Over the past six months, the agency has sent thousands of letters warning pharmaceutical and telehealth firms to remove misleading ads, more than had been sent over the entire preceding decade. Primary violations identified in the letters included making claims implying sameness with FDA-approved products and obscuring product sourcing by advertising drug products branded with the telehealth firm&#39;s name or trademark without qualification, implying they are the compounder. Publicly traded companies that make GLP-1s include Eli Lilly (LLY) and Novo Nordisk (NVO).  
...

StockTwits Web

Lilly(Eli) & Co

Novo Nordisk A/S

DonCorleone77

StockTwits for iOS

 Pay attention to the language folks. Whether it’s an interview on tv or a letter sent to the companies - they keep using the same language over and over and over. Key words: claims, advertisements, marketing. 

This is a marketing issue.

Dad Suggests Stocks

@ClarissaLove And HIMS already fixed it on their website, which is why they aren’t included in this round of letters.

Jewel Gilbert

Cher Farmer

 And HIMS already fixed it on their website, which is why they aren’t included in this round of letters.